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Influence of a low sodium diet on the renal response to amino acid
infusions in humans. In experimental animals, a high protein diet has
been shown to accelerate end-stage renal disease by inducing glomer-
ular hyperperfusion. In this study, we found that intravenous adminis-
tration of amino acid, used as one component of parenteral nutrition, to
normal volunteers resulted in a significant increase in renal blood flow
(from 517 29 to 754 60 mI/mm) and glomerular filtration rate (from
106 6 to 165 12 mI/mm) without altering systemic blood pressure,
renal excretion of electrolytes, plasma renin activity, or plasma aldos-
terone concentration, and excretory rates of prostaglandins E2 were
increased (from 665 61 to 1,034 153 pg/mm). These amino acid—in-
duced renal hemodynamic effects were abolished when the volunteers
received a low sodium diet (20 mEq/day) for three days before the
amino acid infusions. However, the hemodynamic effects were restored
when the subjects receiving low sodium diets were pretreated with
captopril. Under these conditions, amino acid infusions increased renal
blood flow (from 388 11 to 597 27 mI/mm) and glomerular filtration
rate (from 80 4 to 118 9 mI/mm). Reduction of prostaglandin
synthesis with indomethacin in volunteers receiving a normal sodium
intake was also capable of significantly decreasing the amino acid
effects on renal hemodynamics. The results indicate that the renal
hemodynamic effects of amino acid infusion are strongly influenced by
angiotensin II and prostaglandin formation.
It is known that a high protein diet produces a significant
increase in both renal blood flow (RBF) and glomerular filtra-
tion rate (GFR) [1—7]. The mechanisms underlying these renal
hemodynamic effects are unknown [1, 2], but they may be
related to increased concentration of amino acids in blood
because significant increments in GFR have been reported to
occur during the intravenous administration of amino acid
combinations used in parenteral nutrition [7, 8]. However, the
administration of individual amino acids into the renal artery
has failed to either elicit a comparable vasodilatory effect [9—111
or increase GFR [121.
These findings and the observation that the renal vasodilata-
tion induced by a high protein diet is at least in part hormonally
mediated [13—16] have fostered the notion that the overall
effects of protein components on renal function involve a
complex homeostatic response. This concept has raised our
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interest in determining whether the renal effects of amino acids
can be modified by sodium dietary restrictions, which elicit
opposite changes in renal hemodynamics. This question has
considerable clinical significance because a low sodium intake
is regularly administered in most pathologic situations in which
high protein diets are held theoretically responsible for accel-
erating glomerular damage, mainly renal insufficiency [3] and
hypertension [1]. Furthermore, determinations of increments in
GFR induced by protein load [17] or amino acid infusions [8]
have been suggested to be a reliable index of renal reserve,
although it is not known whether such an effect could be altered
by changes in dietary sodium.
This study was therefore undertaken to characterize fully the
effects of amino acid combinations on renal hemodynamics and
on renal excretory function and to determine whether these
effects could be influenced by sodium dietary restriction. A low
sodium diet was found to be efficacious in preventing the renal
hemodynamic effects of amino acid infusions, and this preven-
tive action was reversed by blocking the formation of angioten-
sin II with a converting enzyme inhibitor. Because prostaglan-
dins seem to be important for modulating glomerular dynamics
[181, we also attempted to determine whether the renal re-
sponses to amino acid infusions are modified during treatment
with indomethacin and a normal sodium intake.
Methods
Human volunteers
The study was conducted in 13 healthy volunteers (7 men and
6 women; age range, 24 to 31 years). At the time of admission,
the volunteers had a complete clinical workup; renal function
was determined to be normal from results of standard labora-
tory tests on blood and urine, including creatinine clearance.
After giving written informed consent, approved by the institu-
tional review board, they were hospitalized the night before the
study, and the last meal of unrestricted sodium intake was taken
at 8 p.m. The experimental protocols were conducted at 8 a.m.
the following day. At the completion of the study, the subjects
were closely monitored for symptoms compatible with urinary
infection. In no instance was there a need for further medica-
tion.
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Table 1. Composition of the 10% amino acid solutiona
Amount, g
L Isoleucine 3.09
L-Leucine 4.40
L-Lysine L-glutamate 8.99
L-Methionine 4.19
L-Phenylalanine 4.40
L-Threonine 2.00
L-Tryptophan 0.90
L-Valine 3.00
L-Arginine 7.98
L-Histidine 2.00
L-Alanine 12.00
Polyglycine 19.95
L-Glutamine acetate 9.56
L-Proline 14.00
Sodium L-glutamate• H20 5.61
Sodium disulfite 0.10
Na2EDTA 0.10
Water for injection, to make 1,000 ml
a Composition was derived from a formulation used for parenteral
nutrition. Contains 15 g of nitrogen per liter.
Studies of the effects of amino acid infusions
The effects of amino acid infusions were studied in nine (6
men and 3 women) of the 11 volunteers; the two other volun-
teers were used for control studies in which the effects of
standard solutions that did not contain amino acid were tested.
All subjects lay comfortably in the supine position. The clear-
ances of inulin (C1) and para-aminohippurate (CPAH) were
determined during diuresis, which was elicited by the oral
ingestion of 20 ml of water/kg of body wt during 20 minutes. The
accurate collection of urine was ensured by use of an indwelling
bladder catheter. After an intravenous bolus of inulin and
para-aminohippurate (both substances in 5% dextrose solution
were infused through a butterfly needle inserted into the ante-
cubital vein), infusion was maintained by a constant—infusion
pump (Harvard Apparatus Co., Inc., South Natick, Massachu-
setts, USA). After a 45-minute equilibration period, the bladder
was emptied, and two, 30-minute control clearances were
measured. All the control values reported herein for renal
clearances and urine determinations are the average of two
periods in each subject. Blood samples were drawn at the
midpoint of each clearance through a butterfly needle inserted
into the contralateral antecubital vein; plasma levels of inulin,
para-aminohippurate, sodium, potassium, plasma renin activity
(PRA), and aldosterone were measured. After the control
clearances, a 10% amino acid solution used for parenteral
nutrition (Table 1) was added to the perfusate at a rate of 0.75
mllkg per hour. The total osmolality of the amino acid infusate
was 280 mOsm/liter. The infusion was continued for six hours,
and clearances were measured during the last 30 minutes of
each two hour period. Urine samples were appropriately proc-
essed to measure sodium, potassium, calcium, and phosphate.
Control studies were performed to ensure that the observed
effects were induced by amino acids rather than by the diluent
solutions. Two of the 11 volunteers were submitted to a
protocol identical to that described above for amino acid
infusions except that after the control clearances, which were
also measured by using similar concentrations of inulin and
para-aminohippurate in 5% dextrose solutions, a 0.9% NaCl
physiologic solution that did not contain amino acid was added
to the perfusate. The total amount of the physiologic solution
infused was identical to that of the amino acid solution, and the
total osmolality was adjusted to 280 mOsm/liter by adding
sterilized distilled water.
Studies during a low sodium diet
Seven of the nine patients who received amino acid infusions
were restudied after dietary sodium restriction. Sodium deple-
tion was achieved by administering a single oral dose of
furosemide (80 mg) and a diet containing 20 mEq of sodium and
40 mEq of potassium for three days before the experiment,
which was performed on the morning of the fourth day. The
protocol was identical to that used for amino acid infusions in
the untreated control volunteers.
Studies during a low sodium diet after pretreatment with
captopril
Five of the seven patients in whom the amino acid infusions
were performed during a low sodium diet underwent a five—day
recovery period, during which the total amount of sodium
intake was unrestricted. After these five days of recovery,
furosemide was administered and a low sodium diet was rein-
stituted for three days. The efficacy of the low sodium diet to
reduce fluid volumes was ensured by an average reduction of
body weight of 4.3 0.2 kg and a reduction in the 24-hour urine
sodium value to an average of 21.2 2.1 mEq/24 hours during
the three days. On the fourth day, the patients received an oral
dose (25 mg) of captopril (E. R. Squibb & Sons, Inc., Prince-
ton, New Jersey, USA) one-half hour before the control period
clearance studies were performed.
Indomethacin studies
Seven of the nine patients who received amino acid infusions
during a normal sodium diet underwent a three day recovery
period, after which the effects of amino acid infusion during a
normal sodium diet were again studied after the administration
of indomethacin. Indomethacin, 25 mg twice a day for two days
before the study, was given orally, and the last dose was given
on the morning of the study. The adequacy of inhibition of
prostaglandin synthesis was confirmed by measuring the uri-
nary excretion of prostaglandin E2 (PGE2), as outlined below.
Chemical, hormonal, and blood pressure measurements
The concentrations of para-aminohippurate and inulin in the
blood and urine were estimated by photocolorimetric methods
[19], and the concentrations of sodium and potassium were
estimated by flame photometry (Instrumentation Laboratory,
mc, model 343, Lexington, Massachusetts, USA). Urine cal-
cium was measured by atomic absorption (Perkin—Elmer,
Corp., model 460, Norwalk, Connecticut, USA), and urine
phosphate was measured by the molybdenum blue colorimetric
reaction.
During the procedure, blood pressure was measured every 15
minutes with an automatic recorder (Dynamap Model 845,
Critikon, Inc., Tampa, Florida, USA).
normal sodium diet
Measurementa
Time of measurement"
Control 2 hours 4 hours 6 hours
GFR, mI/mm
RBF, mI/mm
Urine volume, ml!
mm
UNaV, pEq/mnin
FENfl, %
FEK, %
FEB04, %
1Ca, %
PRA, ng/mlperhr
PA, ng!dI
PGE2, pg/mm
Uosm, mOsm/liter
PLosm, mOsm/
liter
106 6
517 29
9.3 1.6
252 38
1.7 0.2
20.3 2.0
9.5 2.2
1.6 0.2
1.4 0.4
2.9 0.4
665 61
125 33
281 3
108 10
526 33
8.6 1.8
248 36
1.6 0.2
21.5 2.5
7.5 1.5
1.8 0.3
1.5 0.5
3.3 0.8
810 110
235 80
277 1
139 12C
614 48C
10.7 1.7
310 54
1.6 0.2
20.6 3.4
10.4 2.4
1.4 0.2
1.0 0.1
3.0 0.6
954 175
151 45
277 2
165 12
754 60C
9.5 1.6
330 51
1.4 0.2
14.6 2.0
10.7 1.1
0.9 0.2
0.8 0.1
2.9 0.3
1,034 153
177 48
278 2
a Abbreviations are: FE, fractional excretion of calcium (Ca), potas-
sium (K), phosphate (P04), and sodium (Na); GFR, glomerular filtra-
tion rate; PA, plasma aldosterone; POE2, prostaglandin E2; PLC,,,,,
plasma osmolality; PRA, plasma renin activity; RBF, renal blood flow;
UNaV, urinary excretion of sodium; Uosm, urinary osmolality.b Values are expressed as mean SE.
P < 0.01.
PRA was measured according to the method of Haber et a!
[20] as modified by Epstein et al [211. Plasma aldosterone was
measured according to the method of Sancho and Haber [221.
POE2 in the urine was measured with a method similar to that
reported previously [231. In brief, this method consisted of a
separation of PGE2 from proteins, neutral lipids, and polar
lipids by organic solvent extraction (ethyl acetate) followed by
purification by solid—phase of siiciic chromatography (Sep-
Pack, Waters Associates, Milford, Massachusetts, USA). Sub-
sequently, PGE2 was separated by high—pressure liquid chro-
matography (Beckman M332, Beckman Instruments, Inc.,
Berkeley, California, USA) and radioimmunoassayed. Gas
chromatography (Carlo Erba, Milan, Italy) and mass spectrom-
etry (Kratos M550, Manchester, UK) were used to ensure that
the radioimmunoassayed material was PGE2.
Statistical analysis
All values were stated as mean SE. Data within and be-
tween groups were analyzed by analysis of variance and Schef-
fe's post-hoc comparison of means. A P value < 0.05 was
statistically significant.
Results
Amino acid infusions during a normal sodium diet
The individual responses of GRF and RBF to amino acid
infusions in subjects receiving a normal sodium diet varied
significantly (Fig. 1), particularly during the first two hours of
the infusion. Thereafter, GFR and RBF followed a significant
upward trend. The average changes in renal hemodynamics,
electrolyte excretion, urinary PGE2, PRA, and plasma aldos-
terone are presented in (Table 2). RBF was unchanged after two
hours of amino acid infusions, but it increased significantly
(P < 0.01) at four and six hours, by 19% and 46%, respectively.
A similar change was observed for GFR, in which the control
/
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Fig. 1. Changes in glomerular filtration rate and renal blood flow
induced by amino acid infusion in subjects on normnal sodium diet.
value was maintained during the first two hours of amino acid
infusion but increased at four and six hours, by 31% and 56%,
respectively (P <0.01). These marked changes in renal hemo-
dynamics were not accompanied by any significant change in
systemic blood pressure; the control values (systolic SE!
diastolic SE, 111 4/74 5 mm Hg) were significantly
alteredattwo(110 5/68 4mmHg),four(114 2/70 4mm
Hg), or six (114 3/66 2 mm Hg) hours during the amino acid
infusion.
The observed increase in the GFR represented a maximal
elevation of the filtered load of sodium of 57%; however, this
change was not accompanied by any significant alteration in
urine volume or in the absolute urinary excretion of sodium.
The fractional excretions of sodium, potassium, calcium, and
phosphate also remained constant (Table 2).
Furthermore, the hemodynamic changes were not accompa-
nied by any alteration in PRA or plasma aldosterone. PGE2
progressively increased by 55%; the differences from the con-
trol value was statistically significant only at six hours during
the infusion.
These results contrast with those obtained in two volunteers
who received a normal sodium diet and were submitted to a
similar experimental protocol except that an equivalent volume
of saline that did not contain amino acids was given with the
intravenous infusions of 5% dextrose solutions used for deter-
minations of renal clearances. In these subjects, the recorded
averages the range of GFR during the control period
(115 19 mllmin) did not increase by more than 0.9% after six
hours of infusions (116 15 mi/mm), and the average control
values of RBF (539 58 ml/min) decreased (535 48 mI/mm)
by 0.74%. Similarly, the observed changes at six hours for the
urinary excretion of sodium (from 242 75 to 238 80
Eq/min), PGE2 (from 652 160 to 661 163 pg/mm), PRA
(from 1.8 0.8 to 1.9 0.6 ng/ml per hour) and plasma
aldosterone (from 2.4 0.8 to 2.6 0.5 ngldl) were not signif-
icant.
Amino acid infusions during a low sodium diet
When the effects of amino acid infusion after sodium deple-
tion were analyzed (Table 3), the control values for most of the
measurements were significantly different from those obtained
during the control period in subjects receiving normal sodium
diets (Table 2). In fact, the administration of furosemide and
three days of sodium dietary restriction induced reductions in
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Table 3. Effects of amino acid infusion in seven patients after sodium
depletion
Measurementa
Time of measurementb
Control 2 hours 4 hours 6 hours
GFR, mI/mm 104 5 111 8 114 11 115 8
RBF, mI/mm 449 29 501 25 471 36 487 24
Urine volume, 7.5 0.1 8.1 1.6 9.3 1.1 9.1 1.3
ml/min
UNaV, pEqimin 56 12 39 7 48 13 53 13
FENa, % 0.4 0.1 0.3 0.1 0.3 0.1 0.3 0.1
FEK, % 14.4 6.9 13.4 1.8 20.4 3.5 18.3 2.6
FEB04, %
FEca, %
12.3 1.0
1.8 0.1
7.4 2.2 11.0 3.3
1.6 0.2 1.4 0.2
13.6 3.7
1.3 0.1
PRA, ng/ml per 3.1 0.2 2.6 0.4 2.4 0.4 3.2 0.5
hr
PA, ng/dl 6.6 0.1 6.9 1.0 7.4 1.1 7.8 1.6
PGE2,pg/min 806 102 1,120 86 1,120 220 855 110
Uosm, mOsml 104 46 208 109 136 41 116 18
liter
PLosm, mOsml 280 2 281 2 281 2 282 1
liter
a Abbreviations are: FE, fractional excretion of calcium (Ca), potas-
sium (K), phosphate (P04), and sodium (Na); GFR, glomerular filtra-
tion rate; PA, plasma aldosterone; PGE2, prostaglandin E2; PLosm,
plasma osmolality; PRA, plasma renin activity; RBF, renal blood flow;
UNaV, urinary excretion of sodium; Uosm, urinary osmolality.b Values are expressed as mean SE.
RBF of 13% (P <0.05), in urinary volume of 19% (P < 0.05),
and in urinary sodium excretion of 78% (P < 0.01). These
changes were accompanied by approximately 2.2-fold increases
in both PRA (P < 0.01) and plasma aldosterone (P < 0.01), and
urinary POE2 increased 21% (P < 0.05). The control values for
blood pressure were also significantly (P < 0.05) decreased, by
approximately 18% (from 111 4/74 5 to 98 3/60 2mm
Hg).
Under the condition of sodium restriction, the effects of
amino acid infusion on renal hemodynamics were significantly
suppressed. The average GFR and RBF values increased after
six hours of infusion by only 10% and 8%, respectively; these
changes were not statistically significant. Amino acid infusion
during sodium depletion did not alter the control values of PRA
or plasma aldosterone, and the urinary excretionrate of PGE2
also remained unaltered.
No significant change occurred in the absolute excretion of
sodium or the fractional excretion of sodium, potassium, cal-
cium, or phosphate. The systemic blood pressure did not
change during amino acid infusion; the control values (103
3/60 2 mm Hg) were not altered at two (103 2/63 2 mm
Hg), four (103 4/65± 4 mm Hg), or six hours (105 3/66 4
mm Hg).
Amino acid infusions during a low sodium diet after
pretreatment with captopril
When the effects of amino acid infusions during a low sodium
diet in subjects pretreated with captopril were studied (Table 4),
the administration of captopril 30 minutes before the experi-
ment resulted in control values for GFR and RBF that were 23%
and 14%, respectively, lower than the control values obtained
in the same subjects during a sodium restricted diet without
Table 4. Effects of amino acid infusion in five patients
depletion and administration of captopril
after sodium
Time of measurementb
Measurementa Control 2 hours 4 hours 6 hours
GFR, mI/mm 80 4 79 6 102 13 118 9C
RBF, mI/mm 388 11 386 18 473 46C 597 27C
Urine volume, 3.1 2.4 6.4 1.4 5.0 1.6 10.2 l.9C
mi/mm
UNaV, pEqlmin 14 4 50 14 55 15C 85 24
FENa, % 0.23 0.10 0.50 0.16 0.47 0.13 0.55 0.16c
FEK, % 6.6 4.7 12.8 7.1 10.3 4.9 10.2 4.7
FE4, % 15.6 7.8 17.1 2.1 11.2 4.4
FEca, % 1.8 0.9 1.5 0.3 2.0 1.0
42.8 19.7
3.7 2.4
PRA, ng/mlper 2.2 1.3 6.8 2.4 8.0 3,lC 6.5 2.4
hr
PA, ng/dl 3,5 0.2 3.2 0.3 2.9 0.2 3.0 0.4
POE2, pg/mm 820 203 — 860 140 890 190
Uosm, mOsmi 121 46 146 31 156 41 201 52
liter
PLom, mOsm/ 280 4 279 3 280 5 282 6
liter
a Abbreviations are: FE, fractional excretion of calcium (Ca), potas-
sium (K), phosphate (P04), and sodium (Na); GFR, glomerular filtra-
tion rate; PA, plasma aldosterone; PGE2, prostaglandin E2; PLosm,
plasma osmolality; PRA, plasma renin activity; RBF, renal blood flow;
UNaV, urinary excretion of sodium; Uom, urinary osmolality.
b Values are expressed as mean SE.
P < 0.01.
receiving captopril (Table 3) (P < 0.01). Captopril also de-
creased (P < 0.01) the control value for urinary sodium excre-
tion by 75% but did not alter the value for PRA or aldosterone
or the urinary excretion rates of POE2.
The infusion of amino acids after the administration of
captopril induced hemodynamic changes comparable to those
obtained in the same subjects when they were untreated and
receiving a normal sodium diet (Table 4). A significant (P <
0.01) increased in the RBF of 21% occurred at four hours and of
53% at six hours; the GFR increased by 27% at four hours and
by 47% at six hours, although this increment achieved statistical
significance (P < 0.01) only at six hours. In addition, the
administration of amino acids to the sodium deprived subjects
who received captopril induced significant (P <0.01) eleva-
tions of both sodium excretion and the levels of PRA, effects
that did not occur when amino acids were given to subjects
while they received a normal or low sodium diet. However, the
levels of plasma aldosterone remained unaltered. Urine volume
and the total and fractional sodium excretion were significantly
(P <0.01) increased by 70%, 84%, and 58%, respectively, and
the value for PRA also increased, by approximately threefold
(P < 0.001). The infusions of amino acids failed to alter the
increased urinary excretion rate of POE2, which exhibited a
higher individual variability.
Control levels of systemic blood pressure (91 3/56 3 mm
Hg) were significantly lower (P <0.05) than when the subjects
received a low sodium diet without captopril pretreatment.
Blood pressure did not change during amino acid infusion (93
3/56 5 mm Hg at two hours, 90 5/56 1 mm Hg at four
hours, and 89 2/55 4 mm Hg at six hours).
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Table 5. Effects of amino acid infusion in seven patients receiving a
normal sodium diet who were pretreated with indomethacin
Time of measurement'
Measurementa Control 2 hours 4 hours 6 hours
GFR, mi/mm 127 13 113 8 125 8 131 7
RBF, mI/mm 473 7 542 32 516 42 609 63
Urine volume, mu 9.0 1 9.1 2.6 11.3 1.2 8.7 1.2
mm
UNaV, pEqlmin 212 68 275 44 233 34 285 39
FENa, % 1.3 0.5 1.7 0.3 1.2 0.2 1.5 0.2
FEK, % 19.8 7.4 25.9 3.4 21,5 1.5 25.1 4.1
FE4, % 9.5 0.4 8.5 2.2 13.3 3.6 16.6 5.7
FEa, % 1.8 0.4 2.1 0.3 1.3 0.2 1.8 0.2
PRA, ng/ml per hr 0.8 0.1 0.5 0.1 0.6 0.1 0.5 0.1
PA, ng/dI 1.2 0.2 1.7 0.7 1.5 0.4 1.6 0.4
PGE2, pg/mm 110 36 173 93 128 8 131 7
Uosm, mOsm/liter 70 29 280 87 114 12 185 29
PLO)m, mOsm/ 274 4 280 6 281 2 283 3
liter
a Abbreviations are: FE, fractional excretion of calcium (Ca), potas-
sium (K), phosphate (P04), and sodium (Na); GFR, glomerular filtra-
tion rate; PA, plasma aldosterone; PGE2, prostaglandin E2; PLosm,
plasma osmolality; PRA, plasma renin activity; RBF, renal blood flow;
UNaV, urinary excretion of sodium; Uosm, urinary osmolality.
b Values are expressed as mean SE.
Amino acid infusions during a normal sodium diet after
administration of indomethacin
The patients who received a normal sodium diet and were
pretreated with indomethacin (50 mg/day) for two days prior to
the experiment also received an additional dose of 50 mg 30
minutes before the determinations for the control period.
The control values for renal hemodynamics and excretion
(Table 5) were not significantly different from those in the same
subjects while they received a similar intake of sodium but no
indomethacin (Table 2). However, PRA, plasma aldosterone,
and PGE2 were significantly decreased by 42% (P < 0.05), 58%
(P < 0.05), and 83% (P < 0.01), respectively. After pretreat-
ment with indomethacin, systemic blood pressure (112 5/76
3 mm Hg) was not different from that of subjects who did not
receive indomethacin and did not change at two (115 4/80
6 mm Hg), four (110 6/78 5 mm Hg), or six hours
(114 5/74 6 mm Hg) of amino acid infusion.
The administration of indomethacin resulted in a complete
suppression of the increments in GFR that the amino acid
infusion induced in the untreated control group (Table 2), and it
significantly (P < 0.05) blunted the increase of RBF by 62%. As
in the control group, the amino acid infusion failed to induce
any significant change in the other renal secretory and hormonal
values, including PGE2, which remained suppressed throughout
the experiment.
When the percentage changes in RBF and GFR induced by
amino acid infusions in the control group of subjects on normal
sodium diet were compared with those of the three experimen-
tal groups (Fig. 2), the profile of increments elicited by amino
acid infusion in the subjects receiving a normal sodium diet was
very similar to that in subjects receiving a low sodium diet and
captopril. This profile contrasts with the lack of significant
changes exhibited by the subjects receiving a low sodium diet
2
Time of amino acid infusion, hr
Fig. 2. Effects of 6 hours of amino acid infusion on glomerular filtration
rate and renal blood flow expressed as percentage change (± SE) from
control for each group of patients. Values measured during control
period were adjusted to 0%. Symbols are: (0) values while receiving
normal sodium diet; (•) values while receiving normal sodium diet and
indomethacin; (LI) values while receiving a low sodium diet; (U) values
while receiving a low sodium diet and captopril. * P < 0.01 compared
with control value within the same group.
but no captopril and those receiving a normal sodium diet
pretreated with indomethacin.
Discussion
Renal effects of amino acid infusions in subjects receiving a
normal sodium intake
This study shows that, in agreement with the reports of other
investigators [7, 8], administration of an amino acid solution
that is commonly infused as one component of parenteral
nutrition is associated with a strikingly large increase in GFR
and RBF. Such effects are comparable to those elicited by
dietary protein, in which changes in chronic intake are accom-
panied by similar changes in GFR 11—7, 91.
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Hemodynamic changes. Although the mechanism that medi-
ates the renal effects of amino acids remains poorly defined,
dietary protein load [4, 17] or amino acid infusions [8] have been
used to estimate renal reserve of glomerular filtration. This
value, which is defined as the ability of the kidney to increase
GFR over resting conditions, was estimated in 28% at 60 and
120 minutes when using a dietary protein load [17], whereas a
14.5% increase in GFR was measured at 24 to 48 hours during
an infusion of amino acid combination [8]. More recently,
37.5% and 45% increments in GFR and RBF, respectively,
were reported to occur in normals two hours after protein load
[24]. Differences in the values of GFR reported in these studies
and in ours could be accounted for by differences in experimen-
tal design, in the relative efficacy of protein load with respect to
amino acid infusions, in the dose and composition of amino acid
preparation, and in the circulating levels of amino acids. Our
results indicate that determinations of renal reserve can be
largely influenced by changes in dietary sodium, fluctuations of
which are difficult to control in free dietary regimens.
Changes in renal excretory function. An important result of
our study was that a 50% increment in RBF and GFR was not
followed by any significant change in renal excretory function.
These effects on RBF resemble those produced by substances
such as secretin or PGE2 synthetic analogues, which are also
capable of inducing renal vasodilatation without changes in
sodium excretion [25, 26]. The natriuretic effect of vasodilators
is largely dependent on their ability to increase renal interstitial
pressure, as is the case with acetylcholine [27] and bradykinin
[28]. On the basis of these findings, one is tempted to speculate
that amino acid—induced renal vasodilatation may not be ac-
companied by changes in interstitial pressure. However, no
study has yet been performed to confirm this possibility.
Another possibility by which the increments in GFR may not
be translated into a significant natriuresis is by assuming an
increase in proximal tubular sodium reabsorption similar to the
increase in the tubular sodium load. Such an assumption was
suggested recently in studies showing that amino acid combi-
nations could greatly stimulate sodium reabsorption in proximal
tubules to the point of decreasing the total amount of fluid flow
that reaches the distal nephron [29]. Such a decrease in distal
tubular flow was suggested to induce, through a tubuloglomer-
ular feedback mechanism, an afferent arteriolar vasodilatation
with an associated increase in GFR. Thus, this hypothesis
provides the conceptual elements that explain not only the lack
of renal sodium excretion during amino acid infusion but also
the parallel increment in RBF and GFR.
Changes in PRA and PGE2. Our study also revealed that the
amino acid—induced renal vasodilatation is not accompanied by
any significant change in peripheral levels of PRA. To a large
extent, this finding could be explained because, during the
experimental period, no acute and significant changes in sys-
temic blood pressure, cardiovascular volume balance, or uri-
nary volume and osmolality occurred that could be incriminated
as responsible for altering renin release through changes in
renal nerve sympathetic—activity [30, 31], intrarenal barorecep-
tors [32], or macula densa receptors [33]. However, during
amino acid infusions, an increase in the excretion rate of PGE2
achieved statistical significance in urine samples collected at six
hours of infusion. Because prostaglandins exert a strong stim-
ulatory influence on renin release [34, 35], one would have
expected a similar change in PRA. This hypothesis assumes
that the overall variations in renal prostaglandin synthesis are
accurately reflected in changes of PGE2 excretory rates [36, 37].
Such an assumption, however, should be constrained by exper-
imental evidence showing that PGI2 may be the only prosta-
glandin capable of modulating renin release [38, 39] and that
urinary excretion of POE2 may not be accompanied by changes
in the synthesis of P012 at the level of the juxtaglomerular
apparatus [40]. Similarly, limited information about the actual
amount of prostaglandins that could effectively diffuse from the
renal parenchyma to the urine may explain why the urinary
excretion rate of these substances did not increase in parallel to
the hemodynamic changes, except at six hours after the amino
acid infusions.
Effects of sodium dietary restriction on renal actions
produced by amino acid infusions.
In the present study, sodium dietary restriction was followed
by the expected decrease in the urinary excretion of sodium and
a concomitant increase in plasma levels of renin and aldoster-
one and in the urinary excretion rate of prostaglandins [41].
Under these conditions, the hemodynamic increments induced
by amino acid infusions were completely abolished, and, as in
controls, the infusions had no effect on the existing elevated
levels of PRA and plasma aldosterone or on the urinary
excretion rate of prostaglandins. The decreased urinary excre-
tion rate of sodium also remained unaltered.
The major clinical implication of this finding is that it ques-
tions the possibility of a deleterious effect of a high protein diet
in patients with essential hypertension and normal renal func-
tion in whom sodium intake is significantly restricted or in
whom a low balance of sodium has been instituted by appro-
priate administration of diuretics [42—44]. Additional studies of
the manner in which changes in dietary sodium could alter the
renal effects of protein intake in hypertension should be con-
ducted to elucidate this important issue.
Effects of inhibition of converting enzymes on the amino
acid—induced renal changes during sodium restriction
The renin—angiotensin system seems to occupy a predomi-
nant place among the renal vasoconstrictor factors activated by
volume depletion subsequent to a low sodium diet. In fact,
several studies indicate that, under these conditions, the in-
creased production of angiotensin II is responsible for a de-
crease in renal hemodynamics [31, 45, 46] and also for sodium
retention [31, 41, 45], which is facilitated not only by increased
levels of aldosterone [31, 33, 45] but also by direct effects that
angiotensin exerts on both renal vasculature and renal tubules
[31, 46]. These findings lend strong support to the assumption
that suppression of the formation of angiotensin II with capto-
pril in sodium depleted subjects was the major factor in both
restoring the hemodynamic effects of amino acid infusions and
fostering the associated natriuresis. An important participation
of prostaglandins in restoring the hemodynamic effects of amino
acids after treatment with captopril is difficult to conceive
because the urinary excretion rates are no different than those
measured in untreated subjects receiving a sodium restricted
diet in whom amino acid infusions fail to induce renal changes.
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It should be mentioned that inhibition of converting enzyme
or kininase II decreases kinin metabolism [47]. However,
because of the undefined role of kinins in renal function [481, it
is difficult to determine how an excessive formation of kinins
could restore the hemodynamic effects of amino acids. In
addition, we have found that, in dogs, a 90% inhibition of
angiotensin I conversion is accompanied by a significant poten-
tiation to bradykinin vascular responses in mesenteric and iliac
vascular beds but not in the renal vasculature [49].
Effects of indomethacin on amino acid—induced changes in
renal hemodynamics
Evidence indicates that the regulation of glomerular dynam-
ics is principally exerted by the renin—angiotensin and the
prostaglandin systems [50]. For this reason, we decided to
study the effects of blockade of prostaglandin synthesis on the
renal hemodynamic response to amino acid infusion. In sub-
jects receiving a normal sodium diet, the administered dose of
indomethacin produced a reduction in urinary prostaglandins of
16% of the excretory rate measured in the untreated control
group under identical dietary conditions. This decrease in
prostaglandin synthesis was accompanied by a decrease in the
levels of PRA and plasma aldosterone similar to that reported
previously by us [41] and by other investigators [35, 50—52].
The effect of indomethacin on resting values of renal hemo-
dynamics is also in agreement with our previous observation
[41] that blockade of prostaglandin synthesis is not expected to
produce a significant change in either RBF or GFR when
indomethacin is given to subjects receiving a normal sodium
intake. Under this condition, the effects of amino acid infusions
on GFR were completely prevented, whereas the increments in
RBF were blunted by 50% when compared with untreated
control subjects receiving a normal sodium intake. These ob-
servations seem to favor the notion that basal synthesis of
prostaglandins is needed to facilitate the effect of amino acids
on renal hemodynamics and that such prostaglandin permissive
actions are critical for the elevation of GFR. Such an interpre-
tation will have to be ascertained with further studies because
the concomitant decrease in PRA that followed the administra-
tion of indomethacin could have hampered the efficacy of
prostaglandin synthesis blockade to prevent the renal hemody-
namic changes completely.
In summary, our study shows that amino acid—induced he-
modynamic effects on the kidney are extensively modulated by
angiotensin II and prostaglandins. These renal hemodynamic
actions of amino acids may not occur during conditions in
which renin activity has been increased (such as a low sodium
diet) but are restored when angiotensin II formation is abolished
by converting enzyme inhibitors. Similarly, a decrease in
prostaglandin synthesis could significantly decrease the amino
acid—induced hemodynamic effects by removing their permis-
sive effects.
Acknowledgments
This study was supported by grants HL-16496 and HL-14133 from the
National Institutes of Health and by the Spanish Ministry of Health. We
thank Dr. T.G. Hammond for his invaluable suggestions in the prepa-
ration of this manuscript, Sherry Lou Linander for her secretarial
assistance, and M.C. Casal and E. Ramos for their technical assistance.
Reprint requests for Dr. J.C. Romero, Department of Physiology and
Biophysics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota
55905, USA.
References
1. BRENNER BM: Hemodynamically mediated glomerular injury and
the progressive nature of kidney disease. Kidney mt 23:647-655,
1983
2. BRENNER BM, MEYER TW, HOSTETTER TH: Dietary protein intake
and the progressive nature of kidney disease: The role of
hemodynamically mediated glomerular injury in the pathogenesis of
progressive glomerular sclerosis in aging, renal ablation, and intrin-
sic renal disease. N Engi J Med 307:652-659, 1982
3. MITCH WE: The influence of the diet on the progression of renal
insufficiency. Annu Rev Med 35:249—264, 1984
4. BOSCH JP, SACCAGGI A, LAUER A, RoNco C, BELLEDONNE M,
GLABMAN S: Renal functional reserve in humans: Effect of protein
intake on glomerular filtration rate. Am J Med 75:943—950, 1983
5. PULLMAN TN, ALVING AS, DE1tr. RJ, LANDOWNE M: The influ-
ence of dietary protein intake on specific renal functions in normal
man. JLab Clin Med44:320—332, 1954
6. O'CONNOR WJ, SUMMERILL RA: The effect of a meal of meat on
glomerular filtration rate in dogs at normal urine flows. J Physiol
(Lond) 256:81—91, 1976
7. Giti' H, STUMMVOLL HK, LUGER A, PRAGER R: Effect of amino
acid infusion on glomerular filtration rate (letter). N EngI J Med
308: 159-160, 1983
8. TERWEE PM, GEERLINGS W, ROSMAN JB, SLUITER WJ, VAN DER
GEEST S, DONKER AJM: Testing renal reserve filtration with an
amino acid solution. Nephron 41:193—199, 1985
9. PITTS RF: The effects of infusing glycin and of varying the dietary
protein intake on renal hemodynamics in the dog. Am J Physiol
142:355—365, 1944
10. PALMORE WP: Glucagon and alanine—induced increases of the
canine renal glomerular filtration rate. Q J Exp Physiol 68:319—327,
1983
11. LEE KE, SUMMERILL RA: Glomerular filtration rate following
administration of individual amino acids in conscious dogs. Q J Exp
Physiol 67:459—465, 1982
12. BREZIS M, SILVA P. EPSTEIN FH: Amino acids induce renal
vasodilatation in isolated perfused kidney: Coupling to oxidative
metabolism. Am J Physiol 247:H999—H 1004, 1984
13. MEYER TW, TROY JL, RENNKE HG, BRENNER BM: Pituitary
ablation preserves glomerular structure and function in rats with
renal ablation. (abstract) IXth International Congress of Nephrol-
ogy, Los Angeles, California, June 11—16, 1984, p. 355A
14. KLEINMAN KS, GLASSOCK RJ: GFR fails to increase following
protein ingestion in growth hormone deficient adults. (abstract)
Kidney In! 27:296, 1985
15. CASTELLINO P. CODA B, DEFRONZO RA: The effect of intravenous
amino acid infusion on renal hemodynamics in man. (abstract)
Kidney mt 27:243, 1985
16. ALVESTRAND A, BERGSTROM J: Glomerular hyperfiltration after
protein ingestion, during glucagon infusion, and in insulin—depend-
ent diabetes is induced by a liver hormone: Deficient production of
this hormone in heptic failure causes hepatorenal syndrome. Lan-
ce! 1:195—197, 1984
17. BOSH JP, LAUER A, GLABMAN S: Short—term protein loading in
assessment of patients with renal disease. Am J Med 77:873—879,
1984
18. DwORKIN LD, IcHIKAwA I, BRENNER BM: Hormonal modulation
of glomerular function. Am J Physiol 244:F95—F104, 1983
19. LIEDTKE RR, DUARTE CG: Laboratory protocols and methods for
the measurement of glomerular filtration rate and renal plasma flow,
in Renal Function Test: Clinical Laboratory Procedures and Diag-
nosis, edited by DUARTE CG Boston, Little Brown Company, 1980,
pp. 49—63
20. HABER E, KOERNER T, PAGE LB, KLIMAN B, PURNODE A:
Application of a radioimmunoassay for angiotensin Ito the physi-
ologic measurements of plasma renin activity in normal human
subjects. J Clin Endocrinol Metab 29:1349—1355, 1969
21. EPSTEIN M, LEVINSON R, SANCHO J, HABER E, RE R: Character-
Renal response to amino acids 999
ization of the renin—aldosterone system in decompensated cirrho-
sis. CircRes4l:818—829, 1977
22. SANCHO J, HABER E: A direct microassay for aldosterone in plasma
extracts. J Clin Endocrinol Metab 47:391—396, 1978
23. RUILOPE L, GARCIA—ROBLE5 R, SANCHO—ROF J, PAYA C, RoDIclo
JL, STRONG CG, KNOX FG, ROMERO JC: Effect of furosemide on
renal function in the stenotic and contralateral kidneys of patients
with renovascular hypertension. Hypertension 5(suppl 5):43—47,
1983
24. HOSTETFER TH: Human renal response. Am J Physiol 250 (pt
2):F613—F618, 1986
25. MERTZ JI, HAAS JA, BERNDT Ti, BURNETT JC JR, KNOX FG:
Effects of secretin on pentubular capillary physical factors and
proximal fluid reabsorption in the rat. J Clin Invest 72:622—625,
1983
26. HAAS JA, HAMMOND TG, GRANGER JP, BLAINE EH, KNOX FG:
Mechanism of natriuresis during intrarenal infusion of prostaglan-
dins. Am J Physiol 247:F475—F479, 1984
27. HARTUPEE DA, BURNETT JC JR, MERTZ ii, KNOX FG: Acetylcho-
line—induced vasodilation without natriuresis during control of
interstitial pressure. Am J Physiol 243:F325—F329, 1982
28. MERTZ JI, HAA5 JA, BERNDT Ti, BURNETT JC JR, KNOX FG:
Effects of bradykinin on renal interstitial pressures and proximal
tubule reabsorption. Am J Physiol 247:F82—F85, 1984
29. WRIGHT F: Intrarenal regulation of glomerular filtration rate. J
Hypertension 2(suppl 1): 105—113, 1984
30. DIBONA OF: The functions of the renal nerves. Rev Physiol
Biochem Pharmacol 94:75—181, 1982
31. ROMERO JC, KNOX FG, OPGENORTH Ti, GRANGER JP, KEISER JA:
Contribution of sympathetic neural reflexes to mineralocorticoid
escape. Fed Proc 44:2382—2387, 1985
32. TOBIAN L: Relationship of juxtaglomerular apparatus to renin and
angiotensin. Circulation 25:189—192, 1962
33. VANDER AJ: Control of renin release. Physiol Rev 47:359—382, 1967
34. ROMERO JC, DUNLAP CL, STRONG CG: The effect of indomethacin
and other anti-inflammatory drugs on the renin—angiotensin system.
J Clin Invest 58:282—288, 1976
35. DUNN Mi: Renal prostaglandins, in Contemporary Nephrology,
(vol 2) edited by KLAHR S, MASSRY S. New York, Plenum
Publishing Corp, 1981, pp. 145—192
36. TANNENBAUM J, Swisu JA, OATES JA, NIES AS: Enhanced
renal prostaglandin production in the dog. I. Effects on renal
function. Circ Res 36:197—203, 1975
37. FROLICH JC, WILSON TW, SWEETMAN BJ, SMIGEL M, NIE5 AS,
CARR K, WATSON iT, OATES JA: Urinary prostaglandins: Identifi-
cation and origin. J Clin Invest 55:763—770, 1975
38. WHORTON AR, SMIGEL M, OATES JA, FROLICH JC: Regional
differences in prostacyclin formation by the kidney: Prostacyclin is
a major prostaglandin of renal cortex. Biochim Biophys Acta
529:176—180, 1978
39. BEIERWALTES WH, SCHRYVER S, SANDERS E, STRAND J, ROMERO
iC: Renin release selectively stimulated by prostaglandin 12 in
isolated rat glomeruli. Am J Physiol 243:F276—F283, 1982
40. BAER P0, BOYD RM, NASJLETTI A: PGI2 synthesis and excretion
in dog kidney: Evidence for renal PG compartmentalization. (ab-
stract) Sixth Scientffic Meeting of the Inter-American Society of
Hypertension. May 19—23, 1985, Cleveland, Ohio, p. 67
41. RUILOPE LM, GARCIA ROBLES R, PAYA C, ALCAZAR JM, MIRA-
VALLES, E, SANCHO—ROF J, Roo J, KNOX FG, ROMERO JC:
Effects of long—term treatment of indomethacin on renal function.
Hypertension 8:677—648, 1986
42. FREIS ED: Salt, volume and the prevention of hypertension.
Circulation 53:589—595, 1976
43. PARIJS J, JoossENs JV, VAN DER LINDEN L, VERSTREKEN 0,
AMORY AKPC: Moderate sodium restriction and diuretics in the
treatment of hypertension. Am Heart J 85:22—34, 1973
44. MORGAN T, GILLIES A, MORGAN 0, ADAM W, WILSON M,
CARNEY 5: Hypertension treated by salt restriction. Lancet
1:227—230, 1978
45. POSTERNAK L, BRUNNER HR, GAVRAS H, BRUNNER DB: Angi-
otension II blockade in normal man: Interaction of renin and
sodium in maintaining blood pressure. Kidney lnt 11:197—203, 1977
46. LEVENS NR, PEACH Mi, CAREY RM: Role of the intrarenal renin
angiotensin system in the control of renal function. Circ Res
48:157—167, 1981
47. YANG HYT, ERDOS EG, LEVIN Y: A dipeptidyl carboxypeptidase
that converts angiotensin I and inactivates bradykinin. Biochim
Biophys Acta 214:374—376, 1970
48. CARRETERO OA, SCICLI AG: The renal kallikrein—kinin system. Am
J Physiol 238:F247—F255, 1980
49. FIKSEN—OLSEN Mi, BRITTON SL, HOUCK PC, ROMERO JC: Effects
of SQ 20881 and captopril on mesenteric, renal, and iliac
vasculatures. Am J Physiol 244:H313—H319, 1983
50. LEVENSON DJ, SIMMONS CE JR, BRENNER BM: Arachidonic acid
metabolism, prostaglandins and the kidney. Am J Med 72:354—374,
1982
51. FROLICH iC, HOLLIFIELD JW, DoRMols JC, FROLICH BL, SEY-
BERTH H, MICHELAKIS AM, OATES JA: Suppression of plasma
renin activity by indomethacin in man. Circ Res 39:447—452, 1976
52. DONKER AiM, ARISZ L, BRENTJENS .JRH, VAN DER HEM GK,
HOLLEMANS HiG: The effect of indomethacin on kidney function
and plasma renin activity in man. Nephron 17:288—296, 1976
